Caricamento...
GENETIC AND PHARMACOLOGICAL EVIDENCE FOR SCHIZOPHRENIA-RELATED DISC1 INTERACTION WITH GSK-3
Recent studies have identified Disrupted-In-Schizophrenia-1 (DISC1) as a strong genetic risk factor associated with schizophrenia. Previously, we have reported that a mutation in the second exon of the DISC1 gene (leucine (L) to proline (P) at amino acid position 100, L100P) leads to the development...
Salvato in:
| Pubblicato in: | Synapse |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485461/ https://ncbi.nlm.nih.gov/pubmed/20687111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/syn.20839 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|